Inventor · disambiguated record
Toshio Kanai
Also filed as: KANAI TOSHIO
7 granted patents·8 pending applications·3 citations·filing 2006–2023
73Inventor score
Files withBOSTON BIOMEDICAL INC4SUMITOMO DAINIPPON PHARMA CO LTD4DAINIPPON SUMITOMO PHARMA CO3SUMITOMO PHARMA CO LTD2FUJITA HITOSHI1
Top patents by PatentIndex Score
15 records- 0177US9688670B2Benzimidazole compounds and medical uses thereofSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2016·Granted Jun 27, 2017·2 cites·23 claims
- 0272US9227962B2Heterocyclic substituted-3-heteroarylidenyl-2-indolinone derivativeDAINIPPON SUMITOMO PHARMA CO·Filed 2014·Granted Jan 5, 2016·1 cites·18 claims
- 0368US2023287009A1Oxo-substituted compoundSUMITOMO PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 0460US11066425B1Oxo-substituted compoundSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2020·Granted Jul 20, 2021·0 cites·27 claims
- 0559US2019241550A1Heterocyclic substituted-3-heteroarylidenyl-2-indolinone derivativeBOSTON BIOMEDICAL INC·Filed 2018·Application pending·0 cites
- 0655US8012971B2Therapeutic agent for chronic obstructive pulmonary diseaseDAINIPPON SUMITOMO PHARMA CO·Filed 2006·Granted Sep 6, 2011·0 cites·1 claims
- 0753US11702431B2Oxo-substituted compoundSUMITOMO PHARMA CO LTD·Filed 2019·Granted Jul 18, 2023·0 cites·68 claims
- 0851US2016075697A1Heterocyclic substituted-3-heteroarylidenyl-2-indolinone derivativeBOSTON BIOMEDICAL INC·Filed 2015·Application pending·0 cites
- 0950US2011034466A1Novel five-membered ring compoundFUJITA HITOSHI·Filed 2009·Application pending·0 cites
- 1048US2016031888A13-(aryl or heteroaryl) methyleneindolin-2-one derivatives as inhibitors of cancer stem cell pathway kinases for the treatment of cancerBOSTON BIOMEDICAL INC·Filed 2014·Application pending·0 cites
- 1147US10407395B2Benzimidazole compound and medical use thereofSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2016·Granted Sep 10, 2019·0 cites·27 claims
- 1247US2019241569A13-(aryl or heteroaryl) methyleneindolin-2-one derivatives as inhibitors of cancer stem cell pathway kinases for the treatment of cancerBOSTON BIOMEDICAL INC·Filed 2018·Application pending·0 cites
- 1345US11066372B2Deuterated benzimidazole compound and medical use thereofSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2018·Granted Jul 20, 2021·0 cites·19 claims
- 1445US2011263550A1Therapeutic agent for chronic obstructive pulmonary diseaseDAINIPPON SUMITOMO PHARMA CO·Filed 2011·Application pending·0 cites
- 1539US2016221948A1Nitrogen-containing saturated heterocyclic compoundSUMITOMO CHEMICAL CO·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Toshio Kanai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →